[Indications and limits of long-term therapy with immunosuppressive (and cytostatic) agents in various chronic skin diseases].
D016918:Arthritis, Reactive / Q000188:drug therapy; D001379:Azathioprine / Q000008:administration & dosage; D002908:Chronic Disease; D003520:Cyclophosphamide / Q000008:administration & dosage; D003882:Dermatomyositis / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007169:Impetigo / Q000188:drug therapy; D008134:Long-Term Care; D008179:Lupus Erythematosus, Discoid / Q000188:drug therapy; D008727:Methotrexate / Q000008:administration & dosage; D010392:Pemphigus / Q000188:drug therapy; D010396:Penicillamine / Q000008:administration & dosage; D010488:Polyarteritis Nodosa / Q000188:drug therapy; D011239:Prednisolone / Q000008:administration & dosage; D011565:Psoriasis / Q000188:drug therapy; D011711:Pyoderma / Q000188:drug therapy; D012595:Scleroderma, Systemic / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*; D014924:Wissler's Syndrome / Q000188:drug therapy
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011239:Prednisolone; D010396:Penicillamine; D001379:Azathioprine; D008727:Methotrexate
Indikationen und Grenzen der Langzeittherapie mit immunsuppressiven (und zytostatischen) Medikamenten bei einigen chronischen Dermatosen.